Hyderabad-based Divi's Laboratories Limited, engaged in the manufacturing of active pharmaceutical ingredient and intermediaries, reported a 11.24% increase in net profit to Rs 117.97 crore for the quarter ended September 2012, as against Rs 106.05 crore in the corresponding quarter last year.
Net income of the company rose 33.67% to Rs 473.74 crore, compared to Rs 354.41 crore a year ago.
Total expense increased 34.65% to Rs 327.54 crore in the quarter, as against Rs 243.26 crore in the corresponding quarter last year. The operating profit margin decreased 50 bps to 30.86% during the quarter, from 31.36% for the same period last year.